Over 400 researchers, industry experts, and emerging talent in glycomics gathered for the 27th International Glycoconjugate Symposium (Glyco27), co-hosted with the 8th Canadian Glycomics Symposium, in Edmonton, Alberta, May 25–30, 2025.
Tag: Karimah Es Sabar
GlycoNet Board Members Honoured with King Charles III Coronation Medal
Congratulations to Karimah Es Sabar and Dr. Jason Acker on receiving the King Charles III Medal for their contributions to the life sciences.
GlycoNet’s Board Chair appointed to Order of British Columbia
Karimah Es Sabar was recently appointed to the Order of British Columbia for being a pioneering force in B.C.’s health care and life sciences sectors.
GlycoNet’s Director Karimah Es Sabar appointed Quark Venture’s new CEO and partner
Karimah Es Sabar named Quark Venture’s new CEO and partner September 20, 2016 By Iris Dorbian Canadian life sciences venture capital firm Quark Venture has appointed Karimah Es Sabar as CEO and partner. Ms. Es Sabar serves on GlycoNet’s Board of Directors and was formerly the president and CEO of the Centre for Drug Research and Development, a […]